Home / BIOVF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does BIOVF make money? Does BIOVF have pricing power? What's the Earnings Whisper? Will BIOVF profit more as the business scales? What is BIOVF's management track record? Is BIOVF's current price justified?

Swedish Orphan Biovitrum AB (publ)

$48.13 +$12.88 (+36.53%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$48.13

Day Range

$47.35$48.13

Year Range

$29.18$49.03

Market Cap

16.71B

AVG Volume

Trailing/Forward PE

110.43/2.06

PEG ratio

4.4

Dividend Yield

Next Earnings Date

2026-10-27

Primary Exchange

Other OTC

Revenue (SEK)

BIOVF Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q2	7.84B
26 Q1	7.18B
25 Q4	7.8B
25 Q3	7.72B
25 Q2	6.17B
25 Q1	6.46B
24 Q4	7.44B
24 Q3	6.89B
24 Q2	5.44B
24 Q1	6.26B

Net Income (SEK)

BIOVF Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q2	1.1B
26 Q1	1.32B
25 Q4	1.86B
25 Q3	-2.88B
25 Q2	636M
25 Q1	875M
24 Q4	1.4B
24 Q3	1.46B
24 Q2	224M
24 Q1	800M

Operating Income (SEK)

BIOVF Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q2	2.07B
26 Q1	1.87B
25 Q4	2.36B
25 Q3	2.81B
25 Q2	1.01B
25 Q1	1.36B
24 Q4	1.66B
24 Q3	2.04B
24 Q2	612M
24 Q1	1.31B

EBITDA (SEK)

BIOVF EBITDA (SEK) by quarter
Period	EBITDA (SEK)
26 Q2	3.33B
26 Q1	2.65B
25 Q4	3.13B
25 Q3	3.63B
25 Q2	2.14B
25 Q1	2.39B
24 Q4	2.59B
24 Q3	2.96B
24 Q2	1.56B
24 Q1	2.38B

Cash Flows (SEK)

BIOVF Cash Flows (SEK) by quarter
Period	Cash Flows (SEK)
26 Q2	1.57B
26 Q1	872M
25 Q4	2.97B
25 Q3	1.82B
25 Q2	1.03B
25 Q1	2.28B
24 Q4	1.74B
24 Q3	-978M
24 Q2	2.29B
24 Q1	1.51B

EPS (SEK)

BIOVF EPS (SEK) by quarter
Period	EPS (SEK)
26 Q2	3.14
26 Q1	3.77
25 Q4	5.33
25 Q3	-8.34
25 Q2	1.83
25 Q1	2.52
24 Q4	4.03
24 Q3	4.22
24 Q2	0.65
24 Q1	2.33

Expenses (SEK)

BIOVF Expenses (SEK) by quarter
Period	Expenses (SEK)
26 Q2	3.16B
26 Q1	3.08B
25 Q4	3.85B
25 Q3	-4.06B
25 Q2	3.29B
25 Q1	2.62B
24 Q4	4.23B
24 Q3	4.83B
24 Q2	2.7B
24 Q1	3.27B

Cash & Debt (SEK)

BIOVF Cash & Debt (SEK) by quarter
Period	Cash & Debt (SEK)
26 Q2	1.08B
26 Q1	940M
25 Q4	1.04B
25 Q3	1.03B
25 Q2	1.06B
25 Q1	997M
24 Q4	1.14B
24 Q3	594M
24 Q2	779M
24 Q1	527M

Debt ratios

BIOVF Debt ratios by quarter
Period	Debt ratios
26 Q2	1.3
26 Q1	1.57
25 Q4	0.93
25 Q3	1.16
25 Q2	1.17
25 Q1	1.37
24 Q4	1.64
24 Q3	1.82
24 Q2	2.03
24 Q1	2.49

Margins

BIOVF Margins by quarter
Period	Margins
26 Q2	76.68%
26 Q1	75.69%
25 Q4	71.47%
25 Q3	-16.25%
25 Q2	76.91%
25 Q1	75.42%
24 Q4	78.48%
24 Q3	80.69%
24 Q2	60.51%
24 Q1	75.24%

Return on Capital

BIOVF Return on Capital by quarter
Period	Return on Capital
26 Q2	2.6%
26 Q1	3.26%
25 Q4	4.94%
25 Q3	-8.05%
25 Q2	1.63%
25 Q1	2.24%
24 Q4	3.47%
24 Q3	3.95%
24 Q2	0.61%
24 Q1	2.23%

Shares Outstanding

BIOVF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	346.18M
26 Q1	345.76M
25 Q4	345.34M
25 Q3	344.65M
25 Q2	343.73M
25 Q1	343.45M
24 Q4	343.23M
24 Q3	343.01M
24 Q2	340.59M
24 Q1	339.83M

Book Value Per Share (SEK)

BIOVF Book Value Per Share (SEK) by quarter
Period	Book Value Per Share (SEK)
26 Q2	122.1
26 Q1	116.79
25 Q4	108.96
25 Q3	103.68
25 Q2	113.66
25 Q1	113.66
24 Q4	117.4
24 Q3	108.19
24 Q2	107.23
24 Q1	105.65

Total Assets (SEK)

BIOVF Total Assets (SEK) by quarter
Period	Total Assets (SEK)
26 Q2	82.89B
26 Q1	81.26B
25 Q4	67.28B
25 Q3	66.5B
25 Q2	68.75B
25 Q1	70.12B
24 Q4	75.44B
24 Q3	72.19B
24 Q2	73.17B
24 Q1	74.52B

PE Ratio

BIOVF PE Ratio by quarter
Period	PE Ratio
Sep 26	172.37
Sep 26	169.79
Aug 26	170.81
Aug 26	168.41
Aug 26	169.4
Aug 26	168.57
Jul 26	169.04
Jul 26	175.67
Jul 26	174.56
Jul 26	174.84
Jul 26	171.21
Jun 26	326.7
Jun 26	321.97
Jun 26	316.31
Jun 26	318
May 26	306.76
May 26	311.13
May 26	313.61
May 26	305.91
May 26	304.97
Apr 26	256.94
Apr 26	255.43
Apr 26	258.37
Apr 26	262.83
Mar 26	4085.54
Mar 26	4027.46
Mar 26	4088.46
Mar 26	3952.48
Feb 26	3480.6
Feb 26	3495.32
Feb 26	3442.78
Feb 26	3483.39
Jan 26	3438.24
Jan 26	3449.65
Jan 26	3561.07
Jan 26	3515.16
Jan 26	3387.46
Dec 25	25.35
Dec 25	25.67
Dec 25	25.65
Dec 25	26.02
Nov 25	25.85
Nov 25	26.13
Nov 25	25.9
Nov 25	26.07
Oct 25	24.79
Oct 25	24.55
Oct 25	24.67
Oct 25	24.85
Oct 25	22.09
Sep 25	24.49
Sep 25	24.52
Sep 25	23.58
Sep 25	23.74
Aug 25	25.04
Aug 25	25.29
Aug 25	23.98
Aug 25	24.72
Aug 25	24.88
Jul 25	24.55
Jul 25	24.94
Jul 25	24.22
Jul 25	24.28
Jun 25	24.48
Jun 25	23.08
Jun 25	26.75
Jun 25	25.77
May 25	25.62
May 25	25.45
May 25	26.28
May 25	26.13
May 25	25.99
Apr 25	24.8
Apr 25	22.93
Apr 25	22.47
Apr 25	25.31
Mar 25	28.01
Mar 25	28.39
Mar 25	29.62
Mar 25	29.51
Feb 25	31.19
Feb 25	31.61
Feb 25	31.76
Feb 25	32.53
Jan 25	33.01
Jan 25	30.14
Jan 25	30.89
Jan 25	30.94
Jan 25	30.64
Dec 24	48.28
Dec 24	50.09
Dec 24	49.82
Dec 24	48.47
Nov 24	47.07
Nov 24	49.56
Nov 24	54.63
Nov 24	53.91
Nov 24	54.62
Oct 24	53.98
Oct 24	49.22

Free Cash Flow Yield

BIOVF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	4.14%
Sep 26	4.21%
Aug 26	4.18%
Aug 26	4.24%
Aug 26	4.22%
Aug 26	4.24%
Jul 26	4.22%
Jul 26	4.07%
Jul 26	4.09%
Jul 26	4.08%
Jul 26	4.17%
Jun 26	5.02%
Jun 26	5.1%
Jun 26	5.19%
Jun 26	5.16%
May 26	5.35%
May 26	5.28%
May 26	5.23%
May 26	5.37%
May 26	5.38%
Apr 26	6.39%
Apr 26	6.43%
Apr 26	6.35%
Apr 26	6.25%
Mar 26	5.09%
Mar 26	5.17%
Mar 26	5.09%
Mar 26	5.26%
Feb 26	5.98%
Feb 26	5.95%
Feb 26	6.04%
Feb 26	5.97%
Jan 26	6.05%
Jan 26	6.03%
Jan 26	5.84%
Jan 26	5.92%
Jan 26	6.14%
Dec 25	3.67%
Dec 25	3.62%
Dec 25	3.63%
Dec 25	3.58%
Nov 25	3.6%
Nov 25	3.56%
Nov 25	3.59%
Nov 25	3.57%
Oct 25	3.75%
Oct 25	3.79%
Oct 25	3.77%
Oct 25	3.75%
Oct 25	4.21%
Sep 25	5.49%
Sep 25	5.49%
Sep 25	5.71%
Sep 25	5.67%
Aug 25	5.37%
Aug 25	5.32%
Aug 25	5.61%
Aug 25	5.44%
Aug 25	5.41%
Jul 25	5.48%
Jul 25	5.39%
Jul 25	5.56%
Jul 25	5.54%
Jun 25	4.79%
Jun 25	5.08%
Jun 25	4.38%
Jun 25	4.55%
May 25	4.58%
May 25	4.61%
May 25	4.46%
May 25	4.49%
May 25	4.51%
Apr 25	4.73%
Apr 25	5.11%
Apr 25	5.22%
Apr 25	4.63%
Mar 25	3.49%
Mar 25	3.44%
Mar 25	3.3%
Mar 25	3.31%
Feb 25	3.13%
Feb 25	3.09%
Feb 25	3.08%
Feb 25	3%
Jan 25	2.96%
Jan 25	3.24%
Jan 25	3.16%
Jan 25	3.16%
Jan 25	3.19%
Dec 24	4.89%
Dec 24	4.71%
Dec 24	4.73%
Dec 24	4.87%
Nov 24	5.01%
Nov 24	4.76%
Nov 24	4.32%
Nov 24	4.38%
Nov 24	4.32%
Oct 24	4.37%
Oct 24	4.79%

Price to Sales

BIOVF Price to Sales by quarter
Period	Price to Sales
Sep 26	5.59
Sep 26	5.5
Aug 26	5.54
Aug 26	5.46
Aug 26	5.49
Aug 26	5.46
Jul 26	5.48
Jul 26	5.7
Jul 26	5.66
Jul 26	5.67
Jul 26	5.55
Jun 26	5.72
Jun 26	5.64
Jun 26	5.54
Jun 26	5.57
May 26	5.37
May 26	5.45
May 26	5.49
May 26	5.36
May 26	5.34
Apr 26	4.5
Apr 26	4.47
Apr 26	4.53
Apr 26	4.6
Mar 26	4.85
Mar 26	4.78
Mar 26	4.85
Mar 26	4.69
Feb 26	4.13
Feb 26	4.15
Feb 26	4.09
Feb 26	4.14
Jan 26	4.08
Jan 26	4.1
Jan 26	4.23
Jan 26	4.17
Jan 26	4.02
Dec 25	4.11
Dec 25	4.16
Dec 25	4.16
Dec 25	4.22
Nov 25	4.19
Nov 25	4.24
Nov 25	4.2
Nov 25	4.23
Oct 25	4.02
Oct 25	3.98
Oct 25	4
Oct 25	4.03
Oct 25	3.58
Sep 25	3.7
Sep 25	3.7
Sep 25	3.56
Sep 25	3.58
Aug 25	3.78
Aug 25	3.82
Aug 25	3.62
Aug 25	3.73
Aug 25	3.76
Jul 25	3.71
Jul 25	3.76
Jul 25	3.66
Jul 25	3.66
Jun 25	3.65
Jun 25	3.45
Jun 25	3.99
Jun 25	3.85
May 25	3.82
May 25	3.8
May 25	3.92
May 25	3.9
May 25	3.88
Apr 25	3.7
Apr 25	3.42
Apr 25	3.35
Apr 25	3.78
Mar 25	3.87
Mar 25	3.92
Mar 25	4.09
Mar 25	4.08
Feb 25	4.31
Feb 25	4.37
Feb 25	4.39
Feb 25	4.49
Jan 25	4.56
Jan 25	4.16
Jan 25	4.27
Jan 25	4.27
Jan 25	4.23
Dec 24	4.36
Dec 24	4.53
Dec 24	4.5
Dec 24	4.38
Nov 24	4.25
Nov 24	4.48
Nov 24	4.94
Nov 24	4.87
Nov 24	4.94
Oct 24	4.88
Oct 24	4.45

EV/EBITDA

BIOVF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	15.54
Sep 26	15.33
Aug 26	15.42
Aug 26	15.22
Aug 26	15.3
Aug 26	15.24
Jul 26	15.27
Jul 26	15.81
Jul 26	15.72
Jul 26	15.74
Jul 26	15.45
Jun 26	15.21
Jun 26	15
Jun 26	14.75
Jun 26	14.83
May 26	14.33
May 26	14.53
May 26	14.63
May 26	14.3
May 26	14.26
Apr 26	12.16
Apr 26	12.09
Apr 26	12.22
Apr 26	12.41
Mar 26	13.7
Mar 26	13.53
Mar 26	13.71
Mar 26	13.3
Feb 26	11.85
Feb 26	11.89
Feb 26	11.73
Feb 26	11.85
Jan 26	11.72
Jan 26	11.75
Jan 26	12.09
Jan 26	11.95
Jan 26	11.56
Dec 25	12.16
Dec 25	12.3
Dec 25	12.29
Dec 25	12.45
Nov 25	12.38
Nov 25	12.5
Nov 25	12.4
Nov 25	12.48
Oct 25	11.92
Oct 25	11.82
Oct 25	11.87
Oct 25	11.95
Oct 25	10.75
Sep 25	11.58
Sep 25	11.59
Sep 25	11.2
Sep 25	11.26
Aug 25	11.81
Aug 25	11.91
Aug 25	11.37
Aug 25	11.67
Aug 25	11.74
Jul 25	11.6
Jul 25	11.77
Jul 25	11.46
Jul 25	11.49
Jun 25	11.66
Jun 25	11.09
Jun 25	12.59
Jun 25	12.19
May 25	12.13
May 25	12.06
May 25	12.4
May 25	12.34
May 25	12.28
Apr 25	11.79
Apr 25	11.03
Apr 25	10.84
Apr 25	12
Mar 25	12.17
Mar 25	12.31
Mar 25	12.77
Mar 25	12.73
Feb 25	13.35
Feb 25	13.5
Feb 25	13.56
Feb 25	13.84
Jan 25	14.02
Jan 25	12.96
Jan 25	13.24
Jan 25	13.26
Jan 25	13.15
Dec 24	14.93
Dec 24	15.41
Dec 24	15.34
Dec 24	14.98
Nov 24	14.6
Nov 24	15.27
Nov 24	16.62
Nov 24	16.43
Nov 24	16.62
Oct 24	16.45
Oct 24	15.18

Price/Operating Cashflow

BIOVF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	21.89
Sep 26	21.56
Aug 26	21.69
Aug 26	21.38
Aug 26	21.51
Aug 26	21.4
Jul 26	21.46
Jul 26	22.3
Jul 26	22.16
Jul 26	22.2
Jul 26	21.74
Jun 26	18.86
Jun 26	18.59
Jun 26	18.26
Jun 26	18.36
May 26	17.71
May 26	17.97
May 26	18.11
May 26	17.66
May 26	17.61
Apr 26	14.84
Apr 26	14.75
Apr 26	14.92
Apr 26	15.18
Mar 26	18.3
Mar 26	18.04
Mar 26	18.31
Mar 26	17.7
Feb 26	15.59
Feb 26	15.65
Feb 26	15.42
Feb 26	15.6
Jan 26	15.4
Jan 26	15.45
Jan 26	15.95
Jan 26	15.74
Jan 26	15.17
Dec 25	16.44
Dec 25	16.65
Dec 25	16.63
Dec 25	16.87
Nov 25	16.76
Nov 25	16.95
Nov 25	16.8
Nov 25	16.91
Oct 25	16.08
Oct 25	15.92
Oct 25	16
Oct 25	16.11
Oct 25	14.33
Sep 25	12.72
Sep 25	12.74
Sep 25	12.25
Sep 25	12.33
Aug 25	13.01
Aug 25	13.14
Aug 25	12.46
Aug 25	12.84
Aug 25	12.93
Jul 25	12.75
Jul 25	12.96
Jul 25	12.58
Jul 25	12.61
Jun 25	12.54
Jun 25	11.82
Jun 25	13.7
Jun 25	13.2
May 25	13.12
May 25	13.04
May 25	13.46
May 25	13.38
May 25	13.31
Apr 25	12.7
Apr 25	11.75
Apr 25	11.51
Apr 25	12.97
Mar 25	14.35
Mar 25	14.54
Mar 25	15.17
Mar 25	15.11
Feb 25	15.98
Feb 25	16.19
Feb 25	16.27
Feb 25	16.66
Jan 25	16.91
Jan 25	15.43
Jan 25	15.82
Jan 25	15.85
Jan 25	15.7
Dec 24	15.41
Dec 24	15.99
Dec 24	15.9
Dec 24	15.47
Nov 24	15.02
Nov 24	15.82
Nov 24	17.44
Nov 24	17.2
Nov 24	17.43
Oct 24	17.23
Oct 24	15.71

Price to Book

BIOVF Price to Book by quarter
Period	Price to Book
Sep 26	4
Sep 26	3.94
Aug 26	3.96
Aug 26	3.9
Aug 26	3.93
Aug 26	3.91
Jul 26	3.92
Jul 26	4.07
Jul 26	4.05
Jul 26	4.05
Jul 26	3.97
Jun 26	4.28
Jun 26	4.22
Jun 26	4.15
Jun 26	4.17
May 26	4.02
May 26	4.08
May 26	4.11
May 26	4.01
May 26	4
Apr 26	3.37
Apr 26	3.35
Apr 26	3.39
Apr 26	3.45
Mar 26	3.77
Mar 26	3.72
Mar 26	3.78
Mar 26	3.65
Feb 26	3.21
Feb 26	3.23
Feb 26	3.18
Feb 26	3.22
Jan 26	3.18
Jan 26	3.19
Jan 26	3.29
Jan 26	3.25
Jan 26	3.13
Dec 25	2.84
Dec 25	2.87
Dec 25	2.87
Dec 25	2.91
Nov 25	2.89
Nov 25	2.92
Nov 25	2.9
Nov 25	2.92
Oct 25	2.77
Oct 25	2.75
Oct 25	2.76
Oct 25	2.78
Oct 25	2.47
Sep 25	2.48
Sep 25	2.49
Sep 25	2.39
Sep 25	2.41
Aug 25	2.54
Aug 25	2.57
Aug 25	2.43
Aug 25	2.51
Aug 25	2.52
Jul 25	2.49
Jul 25	2.53
Jul 25	2.46
Jul 25	2.46
Jun 25	2.36
Jun 25	2.23
Jun 25	2.58
Jun 25	2.48
May 25	2.47
May 25	2.45
May 25	2.53
May 25	2.52
May 25	2.51
Apr 25	2.39
Apr 25	2.21
Apr 25	2.17
Apr 25	2.44
Mar 25	2.65
Mar 25	2.69
Mar 25	2.8
Mar 25	2.79
Feb 25	2.95
Feb 25	2.99
Feb 25	3.01
Feb 25	3.08
Jan 25	3.12
Jan 25	2.85
Jan 25	2.92
Jan 25	2.93
Jan 25	2.9
Dec 24	2.83
Dec 24	2.94
Dec 24	2.92
Dec 24	2.84
Nov 24	2.76
Nov 24	2.91
Nov 24	3.21
Nov 24	3.16
Nov 24	3.21
Oct 24	3.17
Oct 24	2.89

No video analysis for this stock yet. Request one from our team.

News: BIOVF

defenseworld.net · 15 Aug 2026

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Short Interest Update

Swedish Orphan Biovitrum (OTCMKTS:BIOVF - Get Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totaling 649,723 shares, a growth of 139.7% from the July 15th total of 271,067 shares. Currently, 0.2% of the shares of the stock are sold short. Based

AI Analysis

Swedish Orphan Biovitrum AB (publ)

Video analysis: BIOVF

News: BIOVF

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Short Interest Update

Similar companies